Author: Alfa Cytology

Posted Date:

March 30, 2026

Alfa Cytology Boosts TNBC Drug Development Laboratory and Animal Models for Breast Cancer Research

Alfa Cytology

March 30, 2026
One-Stop Oncolytic Bacterial Therapy Development and In Vivo Evaluation Capabilities at Alfa Cytology

Alfa Cytology

March 2, 2026
Alfa Cytology Launches Hu-Immune™ Platform to Facilitate Immunotherapy Candidate Screening and Preclinical Studies

Alfa Cytology

January 28, 2026